More SAWI

An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.
Dr. Continue Reading »

One of the few studies to look at the effects of religious participation on the mental health of minorities suggests that for some of them, religion may actually be contributing to adolescent depression.
Previous research has shown that teens who are active in religious services are depressed less often because it provides these adolescents with social support and a sense of belonging.
But new research has found that this does not hold true for all Continue Reading »

A new mouse model has provided some surprising insight into XLF, a molecule that helps to repair lethal DNA damage. The research, published by Cell Press in the September 5th issue of the journal Molecular Cell, suggests that although XLF shares many properties with well known DNA repair factors, certain cells of the immune system possess an unexpected compensatory mechanism that that can take over for nonfunctional XLF.
Genetic instability Continue Reading »

ImVisioN Therapeutics AG., a biopharmaceutical company pioneering intralymphatic immunotherapy (ILIT™), announced that it has enrolled the first patient for a Phase I clinical study of its lead product IVN201, an immunotherapeutic product for cat dander allergy. The Company also announced the closing of a Series A Financing round of CHF 4.6 M, allowing the clinical development of IVN201. The financing round was led by Aravis Venture Associates Continue Reading »

Clinicians and researchers from around the world attended this week’s 8th International Forum on Mood and Anxiety disorders in Vienna, Austria to discuss the latest advances in the treatment of mood disorders.
A wide range of topics were included in this year’s programme, highlighting the position of IFMAD in the congress calendar as a forum for breaking news, original thinking and debate.
Highlights Continue Reading »